ODDITY Tech recently disclosed its financial outcomes for the first quarter of 2026, revealing a 26% decrease in net revenue. This downturn was primarily attributed to an unexpected surge in customer acquisition costs (CPA), which were twice the anticipated level. Despite these hurdles, the company outperformed its own projection of a 30% revenue drop. Management is actively engaging with its largest advertising partner to rectify technical glitches contributing to the elevated CPA and foresees a return to normalcy in the latter half of 2026. ODDITY Tech has also initiated a share buyback program of up to $200 million and successfully repurchased roughly 6 million shares, underscoring its commitment to shareholder value amidst these operational adjustments. Furthermore, the firm's new dermatology-focused brand, Methodic, launched late last year, is off to a strong start, projected to generate $25 million in revenue this year, demonstrating sustained innovation and strategic diversification.
During the first quarter of 2026, ODDITY Tech faced significant challenges, with its net revenue experiencing a 26% reduction compared to the previous year. This decline, though substantial, was slightly less severe than the 30% drop initially forecast by the company. The primary factor behind this underperformance was a dramatic increase in customer acquisition costs (CPA), which rose to nearly double the expected rates. This unexpected spike in CPA largely stemmed from technical issues with ODDITY's largest advertising platform, hindering its customer outreach efforts.
In response to these issues, ODDITY Tech has been diligently working to implement various recovery strategies. The company has engaged in close collaboration with its major advertising partner, including their top product engineering team, to diagnose and resolve the underlying technical problems. These efforts have included structural and technical adjustments to auditing signals, infrastructure, and campaign setups. Encouragingly, management observed a 28% sequential improvement in CPA from April to May, marking the first positive trend after several months of increases. This suggests that the corrective measures are beginning to yield results, offering a glimmer of hope for a more stable and efficient advertising environment in the coming months.
Despite the current difficulties, ODDITY Tech maintains a bullish long-term outlook. The company's new brand, Methodic, a telehealth platform specializing in dermatology, has shown considerable promise since its launch. Methodic is on track to achieve $25 million in revenue this year, mirroring the successful trajectory of another ODDITY brand, SpoiledChild, in its inaugural year. This brand diversification strategy, coupled with continuous investment in product innovation through OT Labs—which is developing novel molecules for various dermatological conditions—positions ODDITY for future growth. The company remains confident in its ability to navigate the current algorithmic challenges, drawing on past experiences with similar disruptions, and aims to restore its historical pattern of robust growth and profitability.
ODDITY Tech's first quarter of 2026 was characterized by a notable revenue contraction, primarily driven by a significant uptick in customer acquisition costs. Despite this, the company's proactive measures to address technical advertising issues, alongside the promising performance of its new brand, Methodic, illustrate a strategic push towards recovery and sustained market presence. The firm's commitment to innovation and its share buyback initiative further underscore a resolute approach to overcoming short-term hurdles while fostering long-term value creation.
